MedTrace Logo

Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease

NCT06086470 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-10-25

No results posted yet for this study

Summary

The main goal of this clinical study is to evaluate the safety of the Qidni/D Hemodialysis System in patients with end-stage renal disease. The main question it aims to answer is:

Is the Qidni/D safe for performing hemodialysis?

Participants will be subjected to one treatment of hemodialysis for up to 4 hours with the use of the Qidni/D.

Conditions

  • Kidney Disease, End-Stage

Interventions

DEVICE

Qidni/D Hemodialysis System

Qidni/D is a hemodialysis device for patients with end-stage renal disease.

Sponsors & Collaborators

  • Qidni Labs Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Margetts, MD · McMaster University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-07-14
Completion
2024-07-14

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06086470 on ClinicalTrials.gov